The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89bio Inc | EQUITIES | 282559103 | 7,513,618 | 396,497 | SH | SOLE | 396,497 | 0 | 0 | ||
ANI Pharmaceuticals Inc | EQUITIES | 00182C103 | 2,909,027 | 54,041 | SH | SOLE | 54,041 | 0 | 0 | ||
Aclaris Therapeutics Inc | LONG OPTION CALLS | 00461U105 | 6,755,018 | 651,400 | SH | Call | SOLE | 651,400 | 0 | 0 | |
Aclaris Therapeutics Inc | EQUITIES | 00461U105 | 2,273,405 | 219,229 | SH | SOLE | 219,229 | 0 | 0 | ||
Akero Therapeutics Inc | LONG OPTION CALLS | 00973Y108 | 11,039,820 | 236,500 | SH | Call | SOLE | 236,500 | 0 | 0 | |
Akero Therapeutics Inc | EQUITIES | 00973Y108 | 11,268,958 | 241,357 | SH | SOLE | 241,357 | 0 | 0 | ||
Aligos Therapeutics Inc | EQUITIES | 01626L105 | 613,562 | 631,887 | SH | SOLE | 631,887 | 0 | 0 | ||
Alkermes Plc | EQUITIES | G01767105 | 1,252,000 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Allakos Inc | EQUITIES | 01671P100 | 872,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Ambrx Biopharma Inc | EQUITIES | 02290A102 | 1,646,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Annexon Inc | EQUITIES | 03589W102 | 1,372,487 | 389,911 | SH | SOLE | 389,911 | 0 | 0 | ||
BioCryst Pharmaceuticals Inc | EQUITIES | 09058V103 | 5,356,764 | 760,904 | SH | SOLE | 760,904 | 0 | 0 | ||
BioMarin Pharmaceutical Inc | EQUITIES | 09061G101 | 866,800 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Biogen Idec Inc | EQUITIES | 09062X103 | 7,649,362 | 26,854 | SH | SOLE | 26,854 | 0 | 0 | ||
Biohaven Ltd | EQUITIES | G1110E107 | 478,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Bridgebio Pharma Inc | EQUITIES | 10806X102 | 860,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Celldex Therapeutics Inc | EQUITIES | 15117B202 | 339,300 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Cerus Corp | EQUITIES | 157085101 | 2,849,332 | 1,158,265 | SH | SOLE | 1,158,265 | 0 | 0 | ||
Clene Inc | EQUITIES | 185634102 | 219,975 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Cogent Biosciences Inc | EQUITIES | 19240Q201 | 7,340,800 | 620,000 | SH | SOLE | 620,000 | 0 | 0 | ||
Compugen Ltd | EQUITIES | M25722105 | 376,414 | 330,188 | SH | SOLE | 330,188 | 0 | 0 | ||
Cue Biopharma Inc | EQUITIES | 22978P106 | 1,472,417 | 403,402 | SH | SOLE | 403,402 | 0 | 0 | ||
CymaBay Therapeutics Inc | EQUITIES | 23257D103 | 1,752,000 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
Eliem Therapeutics Inc | EQUITIES | 28658R106 | 1,383,449 | 494,089 | SH | SOLE | 494,089 | 0 | 0 | ||
Eloxx Pharmaceuticals Inc | EQUITIES | 29014R202 | 210,352 | 54,075 | SH | SOLE | 54,075 | 0 | 0 | ||
Evogene Ltd | EQUITIES | M4119S104 | 107,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FibroGen Inc | LONG OPTION CALLS | 31572Q808 | 271,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
Fresh Tracks Therapeutics Inc | EQUITIES | 10802T204 | 7,013 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Gilead Sciences Inc | EQUITIES | 375558103 | 4,658,727 | 60,448 | SH | SOLE | 60,448 | 0 | 0 | ||
Glaukos Corp | EQUITIES | 377322102 | 71,210 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
Immatics Nv | EQUITIES | N44445109 | 354,451 | 30,715 | SH | SOLE | 30,715 | 0 | 0 | ||
ImmunoGen Inc | EQUITIES | 45253H101 | 26,795,400 | 1,420,000 | SH | SOLE | 1,420,000 | 0 | 0 | ||
Incyte Corp | EQUITIES | 45337C102 | 2,123,348 | 34,110 | SH | SOLE | 34,110 | 0 | 0 | ||
Insmed Inc | EQUITIES | 457669307 | 3,048,190 | 144,464 | SH | SOLE | 144,464 | 0 | 0 | ||
Intellia Therapeutics Inc | EQUITIES | 45826J105 | 2,073,989 | 50,858 | SH | SOLE | 50,858 | 0 | 0 | ||
Intra-Cellular Therapies Inc | EQUITIES | 46116X101 | 12,583,140 | 198,723 | SH | SOLE | 198,723 | 0 | 0 | ||
Jasper Therapeutics Inc | EQUITIES | 471871103 | 685,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KalVista Pharmaceuticals Inc | EQUITIES | 483497103 | 6,484,572 | 720,508 | SH | SOLE | 720,508 | 0 | 0 | ||
Karyopharm Therapeutics Inc | EQUITIES | 48576U106 | 928,983 | 518,985 | SH | SOLE | 518,985 | 0 | 0 | ||
Krystal Biotech Inc | EQUITIES | 501147102 | 13,963,673 | 118,941 | SH | SOLE | 118,941 | 0 | 0 | ||
MacroGenics Inc | EQUITIES | 556099109 | 6,503,861 | 1,215,675 | SH | SOLE | 1,215,675 | 0 | 0 | ||
Mersana Therapeutics Inc | LONG OPTION CALLS | 59045L106 | 3,619,000 | 1,100,000 | SH | Call | SOLE | 1,100,000 | 0 | 0 | |
Mersana Therapeutics Inc | EQUITIES | 59045L106 | 3,290,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
Merus NV | EQUITIES | N5749R100 | 15,515,084 | 589,255 | SH | SOLE | 589,255 | 0 | 0 | ||
Mirati Therapeutics Inc | LONG OPTION CALLS | 60468T105 | 5,419,500 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
Mirati Therapeutics Inc | EQUITIES | 60468T105 | 3,295,526 | 91,213 | SH | SOLE | 91,213 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | EQUITIES | 604749101 | 2,751,921 | 106,375 | SH | SOLE | 106,375 | 0 | 0 | ||
Monte Rosa Therapeutics Inc | EQUITIES | 61225M102 | 213,419 | 31,156 | SH | SOLE | 31,156 | 0 | 0 | ||
MoonLake Immunotherapeutics | EQUITIES | 61559X104 | 10,200,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Morphic Holding Inc | EQUITIES | 61775R105 | 14,464,875 | 252,309 | SH | SOLE | 252,309 | 0 | 0 | ||
Nuvalent Inc | EQUITIES | 670703107 | 4,852,375 | 115,067 | SH | SOLE | 115,067 | 0 | 0 | ||
Olema Pharmaceuticals Inc | EQUITIES | 68062P106 | 3,525,908 | 390,466 | SH | SOLE | 390,466 | 0 | 0 | ||
Oric Pharmaceuticals Inc | EQUITIES | 68622P109 | 11,258,379 | 1,450,822 | SH | SOLE | 1,450,822 | 0 | 0 | ||
Pharvaris NV | EQUITIES | N69605108 | 3,028,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Phathom Pharmaceuticals Inc | EQUITIES | 71722W107 | 2,864,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Pieris Pharmaceuticals Inc | EQUITIES | 720795103 | 159,101 | 961,338 | SH | SOLE | 961,338 | 0 | 0 | ||
Pliant Therapeutics Inc | EQUITIES | 729139105 | 1,943,678 | 107,267 | SH | SOLE | 107,267 | 0 | 0 | ||
Point Biopharma Global Inc | EQUITIES | 730541109 | 848,922 | 93,700 | SH | SOLE | 93,700 | 0 | 0 | ||
Poseida Therapeutics Inc | EQUITIES | 73730P108 | 5,184,868 | 2,945,948 | SH | SOLE | 2,945,948 | 0 | 0 | ||
Praxis Precision Medicines Inc | EQUITIES | 74006W108 | 3,997,586 | 3,476,162 | SH | SOLE | 3,476,162 | 0 | 0 | ||
Protagonist Therapeutics Inc | EQUITIES | 74366E102 | 690,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
Prothena Corporation PLC | EQUITIES | G72800108 | 3,394,950 | 49,721 | SH | SOLE | 49,721 | 0 | 0 | ||
Reata Pharmaceuticals Inc | EQUITIES | 75615P103 | 1,274,500 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
Rezolute Inc | EQUITIES | 76200L309 | 989,097 | 499,544 | SH | SOLE | 499,544 | 0 | 0 | ||
Rhythm Pharmaceuticals Inc | EQUITIES | 76243J105 | 1,915,610 | 116,168 | SH | SOLE | 116,168 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | WARRANTS | 77313F114 | 19,917 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
Sarepta Therapeutics Inc | EQUITIES | 803607100 | 3,419,567 | 29,860 | SH | SOLE | 29,860 | 0 | 0 | ||
Schrodinger Inc | EQUITIES | 80810D103 | 14,285,556 | 286,169 | SH | SOLE | 286,169 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | EQUITIES | 87164F105 | 418,600 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Tela Bio Inc | EQUITIES | 872381108 | 4,218,537 | 416,440 | SH | SOLE | 416,440 | 0 | 0 | ||
Terns Pharmaceuticals Inc | EQUITIES | 880881107 | 5,247,095 | 599,668 | SH | SOLE | 599,668 | 0 | 0 | ||
Trevi Therapeutics Inc | EQUITIES | 89532M101 | 2,117,358 | 885,924 | SH | SOLE | 885,924 | 0 | 0 | ||
United Therapeutics Corp | EQUITIES | 91307C102 | 6,628,902 | 30,029 | SH | SOLE | 30,029 | 0 | 0 | ||
Ventyx Biosciences Inc | EQUITIES | 92332V107 | 820,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
Veracyte Inc | EQUITIES | 92337F107 | 5,844,117 | 229,451 | SH | SOLE | 229,451 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | EQUITIES | 92532F100 | 4,636,414 | 13,175 | SH | SOLE | 13,175 | 0 | 0 | ||
Viewray Inc | EQUITIES | 92672L107 | 35,220 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Viking Therapeutics Inc | EQUITIES | 92686J106 | 4,191,825 | 258,595 | SH | SOLE | 258,595 | 0 | 0 | ||
Viridian Therapeutics Inc | EQUITIES | 92790C104 | 1,070,550 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
Voyager Therapeutics Inc | EQUITIES | 92915B106 | 1,145,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | EQUITIES | 98420N105 | 3,840,606 | 99,756 | SH | SOLE | 99,756 | 0 | 0 | ||
Zura Bio Ltd | EQUITIES | G9TY5A101 | 1,312,000 | 160,000 | SH | SOLE | 160,000 | 0 | 0 |